AKAM 10-K report for 2025-12-31
Akamai Technologies, Inc. annual report on Form 10‑K for the fiscal year ended December 31, 2025. The filing includes the table of contents, an overview of Akamai’s business and solutions (security, cloud computing and delivery), risk factors, cybersecurity disclosures, and references to the MD&A and financial statements. Key filing metadata (registrant address, auditor, market value, shares outstanding, and filing status) are provided.
Linked assets
AKAM — Akamai Technologies, Inc. (Common Stock, AKAM) is a Nasdaq Global Select Market‑listed large accelerated filer. The 10‑K covers corporate strategy, product offerings (security, compute, delivery), global infrastructure scale (4,300+ edge points of presence across 130+ countries), and a forward‑looking risk discussion. The filing confirms 144,888,114 shares outstanding as of February 16, 2026 and an approximate aggregate market value held by non‑affiliates of $11,183.9 million as of June 30, 2025.
Akamai Technologies, Inc. Form 10‑K for fiscal year ended December 31, 2025. Filing includes company overview, business segments (security; cloud computing; delivery), global infrastructure scale (4,300+ edge points of presence across 130+ countries and ~1,200 network partners), and forward‑looking risk disclosures. Registrant is a Nasdaq Global Select Market‑listed large accelerated filer (AKAM).
This play is based on the company’s filed Form 10‑K (Commission file no. 0‑27275) for the year ended December 31, 2025. The filing provides authoritative corporate disclosures: registrant address (145 Broadway, Cambridge, MA 02142), auditor (PricewaterhouseCoopers LLP, Boston, PCAOB ID 238), aggregate market value held by non‑affiliates of $11,183.9 million as of June 30, 2025, and 144,888,114 shares outstanding as of February 16, 2026. The included table of contents points to material sections (Items 7 and 8) that contain detailed financials and MD&A; the excerpt supplied here is primarily cover, table of contents and business overview, so actionable financial detail requires reviewing Items 7 and 8 in the full filing.
Source proof
Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review
Form 10‑K (Commission file no. 0‑27275) filed by Akamai Technologies, Inc. for the fiscal year ended December 31, 2025. Registrant principal executive office: 145 Broadway, Cambridge, Massachusetts 02142. Auditor: PricewaterhouseCoopers LLP, Boston, Massachusetts (PCAOB ID: 238). The filing includes Table of Contents pointing to Items 1 through 16, including Business, Risk Factors, MD&A (Item 7), Financial Statements (Item 8) and Controls (Item 9A).
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high‑confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As‑is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk‑factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt of CleanSpark, Inc.’s Form 10‑Q for the quarter ended March 31, 2026 contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital‑structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover‑page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk‑factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
Prepared from the company's submitted Form 10‑K; author count: 1. This play bundles public filing metadata and the filing's table of contents and business overview. No separate internal analyst report is included.
Unlock full thesis monitoring
Recommendation: sell (play status: active, outcome: open). The filing provides company and product descriptions plus risk disclosures, but the excerpt here is the filing’s cover, table of contents and business overview — not the full financial statements or detailed MD&A. Use the full Form 10‑K (Items 7 and 8) for earnings, cash flow, balance sheet and other quantitative metrics before making material trading decisions.